Evidence map›Paper›PMID 42426536›Full record

ReviewJournal of cardiovascular translational research2026

Factors Modulating Mitochondrial Function after Arterial Injury: Past-to-Present Evidence for the Devising of Future Preventive and Therapeutic Strategies.

Chollakarn Varopas, Thawatchai Khuanjing, Obuea Homchan, Siriporn C Chattipakorn, Nipon Chattipakorn

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chollakarn VaropasTrauma and Critical Care Unit, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0009-0003-5007-776X
Thawatchai KhuanjingCardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0009-0002-3030-1675
Obuea HomchanTrauma and Critical Care Unit, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Siriporn C ChattipakornCardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0003-1677-7052
Nipon ChattipakornCardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. nipon.chat@cmu.ac.th.ORCID 0000-0003-3026-718X

Funding

Chiang Mai University Center of Excellence AwardNational Research Council of Thailand N42A690147
6 · The paper itself

Abstract

Vascular trauma can lead to adverse outcomes if remodeling is uncontrolled. Intimal hyperplasia (IH) is a key process that contributes to luminal narrowing during remodeling and is strongly influenced by mitochondria. Enhanced mitochondrial ATP production and increased production of reactive oxygen species (ROS), along with reduced apoptosis in vascular smooth muscle cells (VSMCs), have been shown to promote IH. In addition, endothelial injury could initiate mitochondrial dysfunction and apoptosis which compromise endothelial integrity and function, leading to the exposure of VSMCs to various circulating factors, thus triggering IH. Therefore, reduction of mitochondrial ATP production, reduction of ROS, and induction of apoptosis in VSMC after vascular injury may present promising strategies in preventing IH. Conversely, promoting re-endothelialization prevents exposure of VSMCs to blood circulation. This review provides comprehensive insights from in vitro and in vivo reports of potential therapeutic strategies attempt to alleviate IH and achieve optimal outcomes.

Indexed as

ArteriesEnergy MetabolismMitochondriaMitochondria, MuscleMuscle, Smooth, VascularMyocytes, Smooth MuscleVascular RemodelingVascular System InjuriesAdenosine TriphosphateAnimalsApoptosisCardiovascular AgentsHumansHyperplasiaNeointimaOxidative StressAdenosine TriphosphateCardiovascular AgentsReactive Oxygen SpeciesArterial injuryArterial traumaIntimal hyperplasiaMitochondriaVascular injuryVascular trauma

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.